<
New samples of the pharmaceutical industry: Nanyao Group's centralized reform
Release time: 2014-03-27 & nbsp & nbsp & nbsp Source: Anonymous

    A new round of pharmaceutical state -owned assets reform is steadily promoting,Disclosure of Jinling Pharmaceuticals, a subsidiary of Nanyao Group yesterday,Its controlling shareholder Jinling Pharmaceutical Group intends to transfer the control equity to Nanjing New Industry Investment Group,The latter is a state -owned wholly -owned company affiliated to the Nanjing State SASAC。If the equity transfer is successful,Nangan Pharmaceutical Group will no longer own the main pharmaceutical industry platform of Jinling Pharmaceutical。

    Current,Under Nanyao Stake Sports BettingGroup,stake betting appJinling Pharmaceutical、Nanjing Zhongshan Pharmaceutical and Nanjing Bai Jingyu Pharmaceutical are the main pharmaceutical industry assets,Among them, Jinling Pharmaceutical is the most important profitable asset,In recent years, the average annual profit of more than 150 million yuan。South Pharmaceutical Group controls 45.23%of Jinling Pharmaceutical Group through the wholly -owned subsidiary Jinling Pharmaceutical Group,Calculate the average annual profit of about 70 million yuan in the shareholding proportion。

    On the other hand,South Pharmaceutical Group holds 21%of Nanjing Pharmaceutical Group through the wholly -owned subsidiary Nanjing Pharmaceutical Group,Although Nanjing's pharmaceutical profitability is micro,However, the average annual sales scale of the company is close to 20 billion yuan,It is a large -scale pharmaceutical business assets of Nanzao Group。

    The transfer of the controlling stake in Jinling Pharmaceuticals means that the Nanjing State -owned Assets Supervision and Assets Commission opened the prelude to the integration of pharmaceutical assets。Since last year,Pharmaceutical companies with the background of state -owned assets have gradually become integrated,Among them, the Tianjin State -owned Assets Supervision and Administration Commission has the largest integration of state -owned medical assets。

    September last year,Tianjin Pharmaceutical Group intends to transfer 44.04%of the stake online sports bettingequity stake sports betting appof Zhongxin Pharmaceutical from the wholly -owned subsidiary Tianjin Jinhao Pharmaceutical,At that time, Jin Hao Pharmaceutical also controlled China New Pharmaceutical and Lisheng Pharmaceuticals at the same time。After 3 months of implementation,Tianjin Pharmaceutical Group became the controlling shareholder of China -Singapore Pharmaceutical at the end of last year。After entering the master, after entering China New Pharmaceutical,Tianjin Pharmaceutical Group planned a larger action,13681_13716。Data display,Jinlian Group is a wholly -owned subsidiary of Tianjin Pharmaceutical Group,and Ruiyi Holdings are all overseas registered companies,Tianjin State -owned Assets Supervision and Administration Commission and Tianjin Pharmaceutical Group intending to try through this movement of foreign securitization,The current plan is still being implemented。

    In addition,Jiangxi State -owned Assets Supervision and Administration Commission、Lanzhou State -owned Assets Supervision and Administration Commission also shot frequently。The Jiangxi State SASAC will transfer 41.54%of the equity of the Jiangzhong Pharmaceutical Group to Jiangxi Province State -owned Assets Management Company for acting at the end of last year,Build a provincial enterprise industrial investment and financing platform。Lanzhou State -owned Assets Supervision and Administration Commission has scored 100%equity of the major shareholder of the Buddha Pharmaceutical Pharmaceuticals in April last year to the name of the Lanzhou stake betting appState My stake betting appInvestment Corporation。

    According to statistics,Among the current 179 pharmaceutical companies,The actual controller is the State -owned Assets Supervision and Administration Commission of the State Council、Local SASAC、A total of 44 companies of the Municipal State -owned Sinosaic Corporation or Finance Bureau。Where,A considerable number of pharmaceutical companies or their major shareholders have planned equity transfer in the past three years,Especially for the state -owned assets。For example,& ldquo; Tai Chi & rdquo;,The China Resources Department, etc., owned by the State -owned Assets Supervision and Administration Commission of the State Council。

    Under the background of the current state -owned asset integration,Some municipal financial bureaus or state -owned asset companies also intend to deal with their pharmaceutical companies。Ruji Pharmaceutical controlling shareholder Wuxue City State -owned Assets Management Company intends to publicly transfer 15.11%equity of Guangji Pharmaceutical。

    Another,It is understood,Northeast Pharmaceutical and other state -owned background pharmaceutical companies also have the needs of reform。Current,Typical cases of the integrated pharmaceutical industry are the merger and integration of Guangyao Group and the centralized integration of Nanyao Group.,Both are directions for the future internal integration of large pharmaceutical groups。